Product Images Herzuma

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Herzuma NDC 63459-303 by Cephalon, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - herzuma 01

Figure 1 - herzuma 01

Figure 2 - herzuma 02

Figure 2 - herzuma 02

This appears to be a graph showing cumulative incidence rates over time, with time measured in months. The y-axis displays incidence rate percentages ranging from 0%-50%. The x-axis shows the time in months, with the time from randomization. It also includes a chart of "Number at Risk" with the corresponding time points, but the data is not clear due to errors in the .*

Figure 3 - herzuma 03

Figure 3 - herzuma 03

Figure 4 - herzuma 04

Figure 4 - herzuma 04

Figure 5 - herzuma 05

Figure 5 - herzuma 05

PRINCIPAL DISPLAY PANEL - Kit Carton Label - herzuma 06

PRINCIPAL DISPLAY PANEL - Kit Carton Label - herzuma 06

herzuma 07

herzuma 07

This is a graph that shows the survival probability of patients with different treatments over a period of months. The survival probabilities are presented as product-limit survival estimates with the number of subjects at risk. The graph compares the Fluoropyrimidine + Gisplatin treatment with Fluoropyrimicine + Cisplati + Trastuzumab treatment. The duration of survival is measured in months.*

herzuma 08

herzuma 08

This is a prescription multiple-use vial of Herzumar, containing 420mg of trastuzumab-pkrb for intravenous infusion only. No preservatives are included, and the drug must be kept refrigerated. Reconstitution and dilution are required as per the instructions provided. The drug is manufactured by Teva.*

herzuma 09

herzuma 09

The text provides information on a medication called "Herzumar" with the active ingredient "trastuzumab-pkrb". The medication is only available via prescription and comes in a single-dose vial containing 150 mg. The medication must be diluted and administered via intravenous infusion only. The unused portion of the medication should be discarded, and the medication does not contain any preservatives. The medication should be kept refrigerated.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.